SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
40 hedge funds and large institutions have $62.6M invested in Sinovac Biotech, Ltd in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
98% less call options, than puts
Call options by funds: $2K | Put options by funds: $80K
Holders
40
Holding in Top 10
–
Calls
$2K
Puts
$80K
Top Buyers
| 1 | +$900K | |
| 2 | +$892K | |
| 3 | +$274K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$212K |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$130K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$764K | |
| 3 | -$396K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$236K |
| 5 |
Two Sigma Investments
New York
|
-$213K |